Publication Name	World Journal of Cardiology
Manuscript ID	24170
Country	United States

Received	2016-01-12 10:30
Peer-Review Started	2016-01-14 09:59
To Make the First Decision	2016-02-29 15:31
Return for Revision	2016-03-07 12:51
Revised	2016-07-12 21:52
Second Decision	2016-10-13 12:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-10-24 15:08
Articles in Press	2016-10-24 15:08
Publication Fee Transferred	2017-06-06 14:12
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-09-13 06:31
Publish the Manuscript Online	2017-09-25 02:01

ISSN	1949-8462 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	Use of carbon dioxide as an intravascular contrast agent: A review of current literature
Manuscript Source	Unsolicited Manuscript
All Author List	Fahad Ali, Muhammad Asif Mangi, Hiba Rehman and Edo Kaluski
Funding Agency and Grant Number
Corresponding Author	Fahad Ali, MD, Division of Cardiology, Department of Medicine and Lehigh Valley Hospital, P.O. Box 689, Allentown, PA 18105, United States. drfahadalis@yahoo.com
Key Words	Iodinated; Carbon dioxide; Contrast; Vascular; Gadolinium
Core Tip	In patients with renal dysfunction or iodinated contrast allergy, use of iodinated contrast agent poses the risk of considerable morbidity. Similarly, use of gadolinium is discouraged in subject with severe renal dysfunction. Use of carbon dioxide (CO2) as an intravascular con¬trast offers an alternative in such patients for certain procedures, as it is not nephrotoxic and it does not incite allergic reactions. It is inexpensive, readily available and due to its unique physical properties it can be used to image a wide variety of vascular beds and chambers. This article describes the indications, contraindications, adverse effects, instruments, precautions, latest methodologies and data supporting for the use of CO2 as a contrast agent.
Publish Date	2017-09-25 02:01
Citation	Ali F, Mangi MA, Rehman H, Kaluski E. Use of carbon dioxide as an intravascular contrast agent: A review of current literature. World J Cardiol 2017; 9(9): 715-722
URL	http://www.wjgnet.com/1949-8462/full/v9/i9/715.htm
DOI	http://dx.doi.org/10.4330/wjc.v9.i9.715

Full Article (PDF)	WJC-9-715.pdf
Full Article (Word)	WJC-9-715.doc
Manuscript File	24170-Review.docx
Answering Reviewers	24170-Answering reviewers.pdf
Audio Core Tip	24170-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	24170-Conflict-of-interest statement.pdf
Copyright License Agreement	24170-Copyright assignment.pdf
Peer-review Report	24170-Peer-review(s).pdf
Scientific Misconduct Check	24170-Scientific misconduct check.pdf
Scientific Editor Work List	24170-Scientific editor work list.pdf